Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: An investigator-originated compassionate-use experience
Open Access
- 1 September 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 10 (9) , 1125-1128
- https://doi.org/10.1023/a:1008334215414
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatinInternational Journal of Cancer, 1998
- Second-line therapy with paclitaxel and carboplatin for recurrent disease following first-line therapy with paclitaxel and platinum in ovarian or peritoneal carcinoma.Journal of Clinical Oncology, 1998
- Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancerEuropean Journal Of Cancer, 1997
- hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agentsOncogene, 1997
- Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancerAnnals of Oncology, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- High-dose carboplatin and recombinant granulocyte-macrophage colony-stimulating factor in advanced-stage recurrent ovarian cancer.Journal of Clinical Oncology, 1993
- Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population.Journal of Clinical Oncology, 1992
- Phase I study of oxaliplatin in patients with advanced cancerCancer Chemotherapy and Pharmacology, 1990